Use Of Indocyanine Green In Pancreas Surgery

Part of paid clinical trials in Portland, Oregon.

Sponsor
OHSU Knight Cancer Institute
Study ID
NCT06084013
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Non-Interventional Study — OTHER
    Non-interventional study

Study Details

This study evaluates the use of indocyanine green to predict postoperative pancreatic leaks in patients undergoing transection of the pancreas.

Key Dates

Start date
May 17, 2024
Status verified
Jul 2025
Primary completion
Dec 31, 2025
Completion
Feb 28, 2026

Study Design

Enrollment
55 participants (estimated)

Arms

  • Arm: Observational
    Patients receive indocyanine green IV during surgery, undergo imaging and have their medical records reviewed on study.

Primary Outcome Measure

Incidence of biochemical leak or fistula after pancreatectomy. [ Time Frame: Up to 30 days after surgery ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
OHSU Knight Cancer InstitutePortlandOregon97239
Patrick J. Worth
[email protected]
503-346-0243
Patrick J. Worth (PRINCIPAL_INVESTIGATOR)

Find similar trials in Portland, OR

By condition
Pancreatic cancer
By specialty
OncologyGI oncology
By research site
OHSU Knight Cancer Institute· Portland, OR

Related Studies